| Elizabeth Philip, | |
|
1100 Wescott Dr Ste G3, Flemington, NJ 08822-4600 | |
| (908) 788-1710 | |
| (908) 806-2050 |
| Full Name | Elizabeth Philip |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 1100 Wescott Dr Ste G3, Flemington, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003394487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 26NJ00784700 (New Jersey) | Primary |
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023395316 PECOS PAC ID: 9830009711 Enrollment ID: O20120214000288 |
News Archive
Indevus Pharmaceuticals, Inc. has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for NEBIDO (testosterone undecanoate) intramuscular injection, a long-acting testosterone therapy intended to treat male patients with primary and secondary hypogonadism.
Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.
New research being presented today (12 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells - subcutaneous (under the skin) or visceral (around the organs).
The World Health Organization and partners have issued an urgent call for concrete action to better protect health and care workers worldwide from COVID-19 and other health issues.
› Verified 2 days ago
| Entity Name | Hunterdon Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841560158 PECOS PAC ID: 9830009711 Enrollment ID: O20120328000177 |
News Archive
Indevus Pharmaceuticals, Inc. has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for NEBIDO (testosterone undecanoate) intramuscular injection, a long-acting testosterone therapy intended to treat male patients with primary and secondary hypogonadism.
Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.
New research being presented today (12 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells - subcutaneous (under the skin) or visceral (around the organs).
The World Health Organization and partners have issued an urgent call for concrete action to better protect health and care workers worldwide from COVID-19 and other health issues.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Philip, 1100 Wescott Dr Ste G3, Flemington, NJ 08822-4600 Ph: (908) 788-1710 | Elizabeth Philip, 1100 Wescott Dr Ste G3, Flemington, NJ 08822-4600 Ph: (908) 788-1710 |
News Archive
Indevus Pharmaceuticals, Inc. has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for NEBIDO (testosterone undecanoate) intramuscular injection, a long-acting testosterone therapy intended to treat male patients with primary and secondary hypogonadism.
Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.
New research being presented today (12 July) at the UK National Stem Cell Network Annual Science Meeting in Nottingham shows that adding fat to mouse stem cells grown in the lab affects their response to the signals that push them to develop into one or other of the main types of fat storage cells - subcutaneous (under the skin) or visceral (around the organs).
The World Health Organization and partners have issued an urgent call for concrete action to better protect health and care workers worldwide from COVID-19 and other health issues.
› Verified 2 days ago
Elizabeth Mcgourty, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 State Route 31 Ste 111, Flemington, NJ 08822 Phone: 908-284-9880 Fax: 908-782-4316 | |
Dianne C Lakata, RN.,APNC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2100 Wescott Dr, Hbh, Flemington, NJ 08822 Phone: 908-788-6401 Fax: 908-788-6584 | |
Ms. Linda Marie Schnupp, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9100 Westcott Dr, Suite 103, Flemington, NJ 08822 Phone: 908-788-8200 | |
Mrs. Kathryn A. Wall, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 Rt. 31, Ste. 100, Flemington, NJ 08822 Phone: 908-788-6654 Fax: 908-788-6452 | |
Carol Smigelsky, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 111 State Route 31, Suite 121, Flemington, NJ 08822 Phone: 908-782-2825 Fax: 908-782-0196 | |
Kirsten S Posselt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2100 Wescott Dr, Flemington, NJ 08822 Phone: 908-237-5420 |